- Home
- BIO vs ASND Comparison
BIO vs ASND Comparison
Compare BIO & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- ASND
- Stock Information
- Founded
- BIO 1952
- ASND 2006
- Country
- BIO United States
- ASND Denmark
- Employees
- BIO N/A
- ASND 1017
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- BIO Industrials
- ASND Health Care
- Exchange
- BIO Nasdaq
- ASND Nasdaq
- Market Cap
- BIO 9.2B
- ASND 9.1B
- IPO Year
- BIO N/A
- ASND 2015
- Fundamental
- Price
- BIO $245.57
- ASND $152.15
- Analyst Decision
- BIO Strong Buy
- ASND Strong Buy
- Analyst Count
- BIO 4
- ASND 14
- Target Price
- BIO $415.25
- ASND $201.79
- AVG Volume (30 Days)
- BIO 397.4K
- ASND 408.5K
- Earning Date
- BIO 05-06-2025
- ASND 05-01-2025
- Dividend Yield
- BIO N/A
- ASND N/A
- EPS Growth
- BIO N/A
- ASND N/A
- EPS
- BIO N/A
- ASND N/A
- Revenue
- BIO $2,566,500,000.00
- ASND $376,478,932.00
- Revenue This Year
- BIO $1.11
- ASND $61.43
- Revenue Next Year
- BIO $4.55
- ASND $73.07
- P/E Ratio
- BIO N/A
- ASND N/A
- Revenue Growth
- BIO N/A
- ASND 36.34
- 52 Week Low
- BIO $235.84
- ASND $111.09
- 52 Week High
- BIO $387.99
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- BIO 36.97
- ASND 47.92
- Support Level
- BIO $235.84
- ASND $143.81
- Resistance Level
- BIO $249.37
- ASND $158.45
- Average True Range (ATR)
- BIO 7.74
- ASND 6.40
- MACD
- BIO 1.47
- ASND -1.83
- Stochastic Oscillator
- BIO 39.59
- ASND 32.61
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.